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The LAR receptor-like protein tyrosine phosphatase is composed of two intracellular tyrosine phosphatase domains and a 
cell adhesion molecule-like extracellular region containing three immunoglubulin-like domains in combination with eight 
fibronectin type-III-like repeats. This architecture suggests that LAR may function in cellular signalling by the regulation 
of tyrosine phosphorylation through cell-cell or cell-matrix interactions. We used gene targeting in mouse embryonic 
stem cells to generate mice lacking sequences encoding both LAR phosphatase domains. Northern blot analysis of various 
tissues revealed the presence of a truncated LAR mRNA lacking the cytoplasmic tyrosine phosphatase domains and 
indicated that this LAR mutation is not accompanied by obvious changes in the expression levels of one of the LAR-like 
receptor tyrosine phosphatases PTP5 or PTPo\ LAR“'’“ mice develop and grow normally and display no appreciable histologi­
cal tissue abnormalities. However, upon breeding we observed an abnormal neonatal death rate for pups from LAR~;~ 
females. Mammary glands of LAR"7“ females were incapable of delivering milk due to an impaired terminal differentiation 
of alveoli at late pregnancy. As a result, the glands failed to switch to a lactational state and showed a rapid involution 
postpartum. In wild-type mice, LAR expression is regulated during pregnancy reaching maximum levels around Day 16 of 
gestation. Taken together, these findings suggest an important role for LAR-mediated signalling in mammary gland develop­
ment and function. © 1997 Academic Press
INTRODUCTION
Protein tyrosine phosphorylation, a key event in signal 
transduction, is a posttranslational modification controlled 
by the agonistic or antagonistic action of protein tyrosine 
kinases (PTKs) and protein tyrosine phosphatases (PTPases, 
Mourey and Dixon, 1994; Sun and Tonks, 1994). The 
PTPases comprise a diverse family of receptor-like and cyto­
plasmic-type enzymes including multiple isofonns re­
1 Present address: Division of Cell Biology, The Netherlands Can­
cer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Nether­
lands.
suiting from alternative splicing and posttranslational mod­
ifications (for review see Saito, 1993),
Receptor-like PTPases (RPTPases) contain one or two ho­
mologous PTPase domains, a transmembrane segment, and 
diverse combinations of domains with possible ligand-bind­
ing properties in the extracellular part. For example, the 
closely related RPTPases RPTP/i and PTPk mediate cell- 
cell interactions in a homophilic, but not heterophilic man­
ner (Brady-Kalnay et al, 1993; Gebbink et al., 1993; Sap e t  
al,  1994; Zondag et al, 1995). In RPTP/? the extracellular 
moiety binds to a nonrelated cell-surface protein, the neu­
ronal recognition molecule contactin (Peies et al., 1995). It 
has not been clarified if and how such interactions modulate 
tyrosine phosphatase activity and whether RPTPases play
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a role early in signal transduction or later in adaptation or 
response cessation (Ninfa and Dixon, 1994),
Although LAR was among the first RPTPases to be identi­
fied (Streuli et al., 1988) and has been studied extensively 
at the cellular level, its physiological function remains elu­
sive. LAR is composed of two cytoplasmic phosphatase do­
mains in tandem, a transmembrane segment, and an extra­
cellular part which shares homology to immunoglobulin 
(Ig)-like and fibronectin type III (Fn-III) domains, commonly 
found in cell adhesion molecules (Edelman and Crossin, 
1991). This architecture suggests a physiological function 
for LAR in cellular signalling by tyrosine dephosphorylation 
as a response to cell-cell or cell-matrix interactions. Re­
cently, an intracellular LAR-interacting protein (LIP. 1) was 
identified, which binds to the second PTPase domain and 
colocalizes with LAR to the ends of focal adhesions most 
proximal to the cell nucleus, suggesting a role for LAR in 
disassembly of focal adhesions (Serra-Pag&s et al,  1995).
LAR has a broad tissue distribution and is expressed on 
the cell surface as a complex of two noncovalently associ­
ated subunits of 150 and 85 kDa, resulting from cleavage 
of the pro-protein (Streuli e t a l ,  1992; Yu etal., 1992). The 
N-linked glycosylated 150-kDa fragment is shed during 
growth. Whether this shedding, which is PMA-inducible 
(Serra-Pag6s et al., 1994), has an effect on the intracellular 
phosphatase activity remains to be established. The 85-kDa 
fragment contains a short ectodomain, the transmembrane 
segment, and the two PTPase domains of —280 amino acid 
residues each. Two closely related family members do exist 
that show a similar intracellular processing and cell surface 
expression, namely the LAR-like RPTPases PTP5 and FTPcr 
(Pulido e t a l ,  1995a; Yan etal. ,  1993).
In vitro site-directed mutagenesis studies suggested that 
the first, membrane-proximal phosphatase domain of LAR 
exhibits catalytic activity, whereas the second, membrane- 
distal phosphatase domain may have only a regulatory func­
tion in modulating the substrate specificity of the first do­
main (Pot et al,  1991; Streuli et al., 1990). However, the 
extracellular ligand(s) and downstream substrate(s) of LAR 
have not been identified. Therefore, we set out to study the 
consequences of the loss of LAR PTPase function in vivo 
by means of gene targeting using homologous recombina­
tion in mouse embryonic stem (ES) cells. Characterization 
of the resulting LAR“7“ mice points to a role for LAR PTPase 
activity in mammary gland development during pregnancy.
MATERIALS AND METHODS
Generation of LAR-DeRcient Mice
The isolation and characterization of mouse 129 genomic LAR 
sequences were described previously (Schaapveld et al., 1995). A
7.5-kb 5a/r?HI-¿’coRI fragment just upstream of the exons encoding 
the cytoplasmic phosphatase domains was subcloned into pBlue- 
script KS+ (Stratagene). From this, the 3' segment was subcloned as 
a 3.2-kb Pstl-SaA  fragment into a modified pGEM3 vector having a 
X/ioI-linker inserted in the Smal-site, resulting in pLAR5'. From
the 4.5-kb BamHl clone just 448 bp downstream the stop-codon of 
LAR, the 5' 2.3-kb BamHl-Bglil fragment was subcloned into the 
BamHI-site of pLAR5'f generating pLAR5'-3'. Finally, a neomycin 
phosphotransferase expression cassette (Neo) (van Deursen e t al., 
1991) was inserted into the Sa/I-site of pLAR5'-3'. Prior to electro­
poration, the targeting construct (pLARNeo) was linearized using 
the unique A7?oI-site from the introduced linker.
E l4 ES cells were cultured on irradiated SNLH9 feeder cells as 
described (van Deursen and Wieringa, 1992). Exponentially growing 
ES cells were collected and mixed with 20 g of linearized pLAR­
Neo, electroporated at 250 V/500 ¿¿F (Gene Pulser, Bio*Rad), and 
plated at 5 x  IQ6 per 9-cm dish onto irradiated feeder cells. Selection 
was applied 24 hr later using 300 /¿g/ml G418 (Gibco/BRL). After 
9-11 days of selection, G418-resistant ES clones were picked and 
expanded.
Genomic DNA from individual ES cell clones was extracted and 
analyzed by Southern blot analysis as described (Steeghs et al., 
1995). Initial screening was performed using a 3'-flanking probe (a 
Sau3A fragment derived from a 2.5-kb BamHl fragment just down­
stream of the 4.5-kb jBamHI clone mentioned above). Positive 
clones were also analyzed with a 5'-flanking probe (a 1.0~kb 
BamHl -  Xbal fragment representing the 5' end of the 7.5-kb 
BawtH-EcoRl fragment mentioned above), a 0 .8-kb Pstl fragment 
from the Neo cassette, and a 1.8-kb .BamHl mouse LAR cDNA 
fragment comprising all exons encoding both cytoplasmic phospha­
tase domains (Schaapveld et a l, 1995) to check for proper homolo­
gous recombination.
Three correctly targeted ES cell clones that also displayed the 
correct number of 40 chromosomes (CA1, CA7, and BC2) were used 
for injection into C57BL/6 recipient blastocysts and implanted into 
the uterine horns of pseudopregnant (C57BL/6 X CBA/Ca)Fl foster 
mothers (Bradley, 1987), Resulting male chimeras were mated with 
C57BL/6 females to check for germline transmission. DNA ob­
tained from tail biopsies of agouti offspring and subsequent genera­
tions was screened for the presence of the mutant LAR allele by 
Southern blot analysis and/or polymerase chain reaction (PCR, 
Hoffmann-La Roche).
Genotyping
A PCR reaction using four primers was designed to discriminate 
between wild-type (LAR+/+), heterozygous (LAR47"), and homozy­
gous mutant (LAR-7“) mice. The wild-type allele was detected as 
a 542-bp amplicon using the primers LAR5s (5'-GAG CTG CGT 
CAG TTC CA-3', sense), located 129 bp upstream of the codon for 
the conserved cysteine residue in the first phosphatase domain, 
and LAR4as (5'~GAC AGG CTT CCC ACG AC-3', antisense), a 
genomic primer located 410 bp downstream of the same cysteine 
codon. The mutant allele was detected as a 394-bp amplicon using 
the primers Neo3' (5'-CTA TCG CCT TCT TGA CGA GTT-3', 
sense), located 25 bp upstream of the stop-codon in the Neo cas­
sette, and LAR2as (5'-GAC TTG CTC AGG TAG GGC-3', anti­
sense), located 532-bp downstream of the stop-codon of LAR. The 
PCR cycle profile consisted of 94°C for 1 min, 59°C for 1 min, and 
72°C for 1 min, for 35 cycles, and was performed in a programmable 
thermocycler (Perkin-Elmer-Cetus). Each 50-//1 reaction con­
tained 10 mM Tris-HCl (pH 8.3), 50 mM  KCl, 2.5 m M  MgC\z , 
0.01% BSA, 0.01% gelatin, 0.05% NP-40, 0.05% Tween-20, 1 mM  
dNTPs, 100 ng genomic DNA, 100 ng of each primer, and 1 U Taq 
polymerase. One-fifth of the reaction products was separated on 
2% agarose gels and visualized by ethidium bromide staining.
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Breeding of Mice
Mice were kept at the Central Animal Facilty of the University 
of Nijmegen in a standard room with a day/night rhythm of 06:00/ 
18:00 hr at a temperature of 21°C and a humidity of 50-60%. Males 
were housed together with four females in a macrolon type I cage 
and fed ad libitum. Upon pregnancy, females were separated to 
give birth to their pups. The first, second, and third litter of each 
female was counted and pups were observed eveiy day. Experiments 
were performed on F2 mice with a 129X C57BL/6 hybrid genetic 
background. Breeding results were statistically analyzed using MA- 
NOVA (SPSS) and Student’s t test.
RNA Analysis
Poly (A)+ RNA from kidney, brain, heart, liver, and lung (pooled 
from four 3-months-old male LARW+, LAR+/_, and LAR_/~ mice, 
respectively) was isolated as described previously (Hendriks et al., 
1995). For Northern blot analysis, 3 ¿¿g of each sample was fraction­
ated on a 1% (w/v) agarose/2.2 M  formaldehyde gel, transferred to 
a Hybond-N+ membrane (Amersham), and linked by UV-radiation 
(UV Stratalinker 1800, Stratagene). Blots were subsequently probed 
with the 1,8-kb BamHl mouse LAR cDNA fragment described 
above, a 162-bp EcoRl fragment from mouse LAR cDNA#9 up­
stream of the deleted region (Schaapveld etal., 1995), a 1.1-kb Xhol 
fragment from the Neo cassette, and mouse cDNA probes (Schaap­
veld et al., 1995) spanning the phosphatase domains of the LAR- 
like RPTPases PTP<5 (pos. 2486-3815, Mizuno et al., 1993) and 
PTPcr (pos. 4518-3' UTR, Ogata et al., 1994), respectively. A rat
1.3-kb Pstl glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
cDNA probe (Fort et al., 1985) was used to enable comparison of 
RNA loading. Hybridization signals on autoradiograms were ana­
lyzed on a GS-670 imaging densitometer (Bio-Rad). Hybridized 
probes were stripped for 10 min in boiling O.lX SSC/0.1% SDS. 
Removal of probes was checked by exposing filters overnight be­
tween hybridizations.
For analysis of LAR expression during mammary gland postnatal 
development, the first inguinal glands of 3 -4  wild-type mice were 
collected (pregnancy staged by detection of vaginal plug) and RNA 
was prepared according to Chomzynski and Sacchi (1987). Total 
RNA (20 /¿g) was separated on a 1.5% form aldehyde-agarose gel, 
transferred to Nylon membrane (GeneScreen Plus), and hybridized 
with the LAR, PTP5, PTPcr, and GAPDH probes described above, 
and with a 28S rRNA probe. Phosphor-image analysis was per­
formed using a Model GS-363 Molecular Imager System (Bio-Rad) 
and Molecular Analyst software (Bio-Rad) to quantify the relative 
expression levels.
Analysis of milk protein expression was done as described pre­
viously (Robinson et a l, 1995). Briefly, the first inguinal glands of 
nonlactating LAR_/_ and wild-type mice at 18.5 days of pregnancy 
and at parturition were collected and RNA isolated. For hybridiza­
tions, oligonucleotide probes specific for WDNM1, WAP, /?-casein, 
and a-lactalbumin were used.
Histological Analysis
Various tissues from 7-, 14-, and 21-weeks-old mice (male and 
females) were dissected, fixed in buffered formaldehyde, dehy­
drated, and embedded in paraffin. Sections of 6-//m thickness were 
stained with haematoxylin-eosin according to standard histological 
procedures. Brains were analyzed using parasagittal and coronal 
sections stained with cresyl violet.
For analyses of mammary glands only female mice with a known 
history (2-3 litters) regarding neonatal death were used. At the 
appropiate time point during pregnancy mice were anesthetized 
with Avertin (Aldrich) and glands were taken surgically, Mice were 
subsequently allowed to recover and to give birth to their pups. At 
parturiton and the appropiate time point during the lactation period 
mice were sacrificed by cervical dislocation.
For histological analyses of mammary glands, the right first in­
guinal mammary glands were dissected, fixed, and embedded in 
paraffin as described above. Five-micrometer sections were stained 
with haematoxylin-eosin or used for immunohistochemical detec­
tion of WAP protein as described earlier (Robinson et al., 1995). 
Mammary glands were also frozen in liquid N 2 and embedded in 
Tissue-Tek O.C.T. Compound (Miles). Serial cryostat-sections of 
10 (im were stained with oil-red O to enable detection of lipid 
vesicles, or with haematoxylin-eosin.
For whole mount preparations of mammary glands the left sec­
ond thoracic and first inguinal mammaiy fat pads were dissected, 
mounted on glass slides, fixed, and stained with Delafield’s haema- 
toxylin or carmine as described (Edwards e t al., 1988). Subse­
quently, they were made transparent by immersing in methyl sali­
cylate, analyzed using a dissecting microscope, and photographed. 
As controls for mouse strain-specific differences, mammary glands 
from 129, C57BL/6, and (129X C57BL/6)F1 females were included 
in the analysis.
Milk Protein Analysis
Milk collection was done essentially as described (Simons et al, 
1987). At Day 2 of lactation (day of birth of pups is taken as Day 0), 
female mice were separated from their pups and 2 hr later injected 
intrap eri tone ally with 1 or 2 I.U. oxytocin (Intervet). After 10 min 
milk collection was started.
RESULTS
Targeted Deletion of the LAR Phosphatase Domain 
Gene Sequences
To study LAR function in an organismal context we used 
gene targeting by homologous recombination in ES cells to 
produce LAR~y~ mice. A replacement-type targeting vector 
was constructed in which a positive selection marker, a 1.1- 
kb neomycin phosphotransferase expression cassette (Neo), 
is flanked by 3.2 and 2.3-kb of endogenous LAR genomic 
segments (Schaapveld etal., 1995) which provide the neces­
sary homology for targeted integration. Upon correct ho­
mologous recombination, a 4.5-kb genomic segment con­
taining all exons encoding the phosphatase domains of LAR, 
is replaced by the Neo cassette in the same transcriptional 
orientation (Fig. 1 A). This event results in a shorter BamHl 
fragment (12.0 to 8.6 kb) and EcoRV fragment (20.5 to 12.0 
kb) spanning the 5' and 3' regions of homology, respectively. 
This targeting construct was introduced into El 4 ES cells 
by electroporation and 365 G418-resistant clones were 
screened for homologous recombination. Southern blot 
analysis using 5'- and 3'-diagnostic probes derived from ge­
nomic DNA flanking the targeting vector region revealed a 
targeting frequency of about 1 in 50 clones. Three cell lines
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FIG. I, Disruption of the LAR gene by homologous recombination. (A) LAR protein structure showing the relevant functional domains. 
[g> Immunoglobulin-like domains: Fn-ilf, fibronectin typo Hi I ike domains; FTP, tyrosine phosphatase domains 1 and 2. The LAR cDNA 
probes as used for Northern blot analysis (see Fig. 2) are indicated by solid bars. Below, a schematic diagram of the relevant part of the 
mouse genomic LAR locus arid the targeting strategy are shown. Hatched bar’s in pLARNeo represent the fragments homologous to 
endogenous LAR genomic, segments and the  gray arrow symbolizes the neomycin phosphotransferase selection cassette. Small gray bars 
indicate the 5'- and 3 '-diagnostic probes, and the solid bars 1 and 2 mark the  genomic segments encoding the phosphatase domains 1 and
2, respectively. 13, Ban ¡Hi; E, licoRi: V, EcoRV; P, Psil, (B) Southern blot analysis of tail DNA from wild-type (+/+), mice heterozygous 
(-1-/-), and mice homozygous ( - / —) for the mutant LAR allele, The LAR 5'- and 3 '-flanking probes (A and B) reveal the m utant diagnostic
8.6-kb BaniHl and 12.0-kb EcoRV fragments next to the wild-type 12,0-kb Barul if and 20.5-kb EcoRV fragments, respectively. Hybridization 
with a LAR cDNA probe encompassing both phosphatase domains confirms the total absence of these sequences in LAR”7“ mice (C). A 
Neo cDNA probe reveals the absence of additional integrations of the targeting vector (D).
displaying correct homologous recombination and a normal 
karyotype were injected into blastocysts. C him a eric males 
derived from all three ceil lines were mated with C57BL/6 
females and shown to transmit, the ES cell genome. Off­
spring carrying the desired mutation were then sibling 
mated and used to produce heterozygous and homozygous 
mutant mice in a mixed 129x C57BL/6 background.
To ve r i fy t h e p res enee o f t he c o rr ec t r e pi ac ern e n t m u ta - 
tion in our lines, offspring born from Fl heterozygote 
crosses were ge no typed by Southern blot (Fig. IB) or PCR 
analysis of genomic DNA isolated from tail biopsies. The 
5'- and 3 '-flanking probes revealed the correct targeting of 
the LAR locus (Fig. IB, panels A and B). A LAR cDNA probe 
encompassing both phosphatase domains (Schaapveld et ah, 
1995) failed to detect the wild-type 12.0-kb B ambii fragment, 
in DNA isolated from homozygous mutant mice, as antici­
pated (Fig. I B, panel C). Using the neorrtycin-resista nee gene 
as a probe, oniy the 12.0-kb EcoRV frag rnen t and no addi-
tion al integrations of the targeting construct, were detected 
(Fig. IB, panel D).
g o u s
The mutant LAR allele was identified in 145 heterozy-
’f/~, 49,7%) and 68 homozygous (LAR~/~, 23,3%) 
mice out of a total of 292 mice tested. Thus, the mutant 
allele segregated essentially according to Mendelian laws, 
indicating that the removal of the LAR PTPase domains is 
not lethal.
The Mutant LAR Allele Produces a Truncated 
niRNA
ib  investigate the consequences of LAR gene targeting 
at the RNA level, poly(A)+ RNA was isolated from several 
tissues and analyzed by Northern blot analysis (Fig. 2). Us­
ing the mouse LAR cDNA encompassing both LAR PTPase 
domains as a probe, no wild-type LAR rn RNA was detected 
in LAR-7“ mice (Fig. 2A). The faint signals present in the 
LAR“7“ brain isolate are due to cross-hybridization to the 
i  i g h ly h o m o 1 o g o u s RP TP a s e PTP a (Schaapveld et a i.  1995, 
see also below). Total absence of LAR mRNA containing 
the PTPase domains was confirmed by RT-PCR using
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FIG, 2, Northern blot analysis of poly (A)+ RNA isolated from vari­
ous tissues from LAR*7*, LAR*7 , and LAR ' mice usine
probes: (A) A mouse LAR cDNA encompassing both PTPase do­
mains of LAR; (B) A mouse LAR cDNA EcoRl fragment upstream 
of the deleted region (ALAR); (C) A Neo cDNA Xhol fragment; (D) 
A mouse PTP<$ cDNA; (E) A mouse PTPcr cDNA clone; and (F) A 
rat GAPDH cDNA Pstl fragment is used to verify the integrity of 
the RNA loaded. The positions of the 28S and IBS ribosomal bands 
are indicated on the right.
mouse LAR-specific primers and poly (A)4 RNA isolated 
from various tissues (data not shown), in .inRNA isolated 
from wild-type brain, an additional in RNA isoform of —6.5 
kb is seen along with the ubiquitously expressed messenger
o f - 8  kb.
The m u tan t  LAR allele is expected to give rise to shorter 
transcripts that, contain the sequences encoding the LAR 
extracellular region and ending at the poly (A) addition site 
present in the Neo cassette, Indeed both an EcoRl mouse 
LAR cDNA fragment located ju s t  upstream of the deleted 
region and the neomycin-resistance gene probe detect a 
— 5.5-kb mRNA (Figs. 2.B and 2C). In brain a —4-kb tran ­
script is also found in LAR+7“ and LAR"7” mice that likely 
encodes a shorter LAR iso form lacking extracellular region
sequences (O’Grady eta]., 1994; Zhang and Longo, 1995). 
Th e tru nca tecl tr anscri p t (s) 1 n the L A R"7” m  ice, if tra nsI a ted 
a t a 11, e n cod e (s) a m u t a t e cl LAR m o 1 e c u 1 e th a 1 1 a c ks P TP a s e 
activity.
Histological Analysis o f LAR Mutant Mice
Mice lacking the LAR PTPase domains had normal 
w e i g I it;, be ha v e d n o r m a 11 y a n d a p p e a re cl h e a 11 h y u p o n v e l e r - 
inary inspection. We then performed an extensive histologi­
cal survey to look for possible consequences of the absence 
of functional LAR  at the tissue and cellular level. A wide 
variety of tissues, including brain, kidney, adrenal, Liver, 
lung, heart, stomach, colon, ileum, duodenum, testis, 
uterus, pancreas, muscle, spleen, thymus, and m am m ary 
gland were iso 1 atecl frorn 6-, 14-, and 21 -w eek-o 1 d rna 1 e ancl 
fe m a 1 e m 1 c e , sect! on e cl,  a n ci s t a 1 n e cl w i th hae rn a Coxy 1 i n - e o -  
sin, In addition, serial parasagittal and coronal sections of 
brain were stained with cresyl violet. This analysis revealed 
no significant differences between LAR*7*, LAR*7” , and 
LAR"7“ mice (data not shown),
Expression of LAR-like RPTPases
The .LAR-like RPTPases, PTP<5 (Mizuno et ah, 1993), and 
PTPa (Ogata et ah, 1994; Wagner et ah, 1994), are —90% 
identical to LAR at the amino acicl level for both PTPase 
d orn ai n s (S ch a a p v e 1 d e t ah, .1995), ex h 1 b i t s im i I ar in vi tro 
PTPase activity, and all three interact w ith  the LAR-inter- 
acting protein, LIP.1, suggesting similar functions in vari­
ous tissues (Pulido et ah, 1995b). To determine w hether 
FTPd and/or PTPa could compensate for LAR function in 
the LAR"7" mice, we performed Northern blot analysis us­
ing mouse cDNA probes encompassing the cytoplasmic re- 
g 1 ons of PTP8 aricl PTPa (Schaapveld et ah, .1995), Signal 
quantitation by densitometry revealed no significant differ­
ence in mRNA levels of PTP 6 or PTPcr in LA IT'7 ~ mice 
compared with LAR4'7"" and LAR+/+ mice (Figs. 2D and 2E), 
and the expression distribution of the tissue-specific alter­
native mRNA isoforms was consistent w ith  data published 
elsewhere (Mizuno et ah, 1993; Ogata et ai., 1994; Wagner 
et ah, 1994). This finding cannot rule out any redundancy 
at the enzymatic level and ultimately crosses between 
LAR-, PTP 8-, ancl PTPa-negative mice will be needed to 
reveal a potential overlap in function between these 
RPTPase subfam ily m embers.
Increased Neona tal Mortality for Pups from LAR / 
Fern ¿ties
Unexpectedly upon interbreeding LAR™7” males and fe­
males normal-sized litters were obtained, but m any of the 
pups died within .1 -3  clays after birth. To substantiate this 
finding, an extensive breeding program was performed in 
which four possible intercrosses were examined (Fig. 3). We 
observed an increased neonatal death rate for pups from 
~7~ mothers (>50%) compared to pups from LAR+/+
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FIG. 3. Increased neonatal mortality for pups of LAR"/_ female mice. Upon breeding, LAR“7'  females show normal fertility and give 
birth to normal-sized litters. However, >50% of the pups die within 1 -3  days after birth compared to only < 10% in the case of LAR+/+ 
females The ratio death/born (96) are indicated reflecting the lack of complete penetrance of the phenotype. Comparable results were 
found for second and third litters (data not shown). Diagram represents the sum of results with mice derived from the CA1 and BC2 ES 
cell clones.
mothers (<10%, t(27,48) = 5.13, P <  0.001), independent 
of the male genotype and litter size (F(2,30) — 0.08, P = 
0.921). This reduced survival rate was a consistent finding 
for all three independently derived LAR knock-out lines 
(originating from ES cell lines CA1, CA7, and BC2) and 
comparable results were observed for the second and third 
litters from the same LAR“/_ females (data not shown). On­
going studies using female mice that result from multiple 
backcrosses onto C57BL/6 background point to full pene­
trance in C57BL/6 mice with respect to the neonatal death. 
Thus, most likely the heterogeneity of the genetic back­
ground (hybrid 129X C57BL/6) explains the variable pene­
trance that was observed using F2 animals.
At autopsy, pups born from LAR_/" females which died 
at Days 1-3 postpartum appeared smaller compared with 
pups of the same age born from wild-type mice. As indicated 
by the absence of a white colored belly, no milk was found 
in their stomachs. Because milk ingestion failed despite 
multiple attempts to suckle the mothers’ nipple, we attri­
bute the neonatal death to a defect in the lactating capacity 
of the LAR”/_ mothers rather than to a behavioral abnormal­
ity of neonates. To validate this observation, 1-day-old 
LAR_/" pups from LAR~7~ parents without white bellies 
were swapped to lactating wild-type mothers. These pups 
survived demonstrating that their suckling capacity was 
normal. In contrast, 1-day-old healthy looking LAR+/+ pups 
from wild-type parents were accepted by LAR~/_ mothers 
and did suckle their nipples, but dehydrated and died within 
5 days (data not shown).
To investigate a possible milk production defect in 
LAR-/~ mothers in more detail, the quantity of the milk 
produced by these mice was analyzed. In contrast to lactat­
ing LAR+/+, LAR+/~, or LAR-/" mothers from which normal 
amounts of milk (20-50 ¿¿1) could be readily obtained al­
ready at postpartum, we never obtained more than 2-3 pi 
milk from LAR~;~ mothers whose pups died within 1-3 
days. Neither the injection of higher doses of oxytocin (2-
5 LU.) nor the intensive massaging of the mammary glands 
helped to increase milk production (data not shown), sug­
gesting that the lactational defect in LAR"7“ mice may be 
due to a general lack of milk protein synthesis or impaired 
milk secretion.
Regulation of LAR Expression during Pregnancy
To determine whether LAR has a role in mammary gland 
development and function, we examined LAR mRNA ex­
pression in mammary glands isolated from female mice at 
various stages during postnatal development LAR expres­
sion is already present in mammary glands of virgin females 
as determined by RT-PCR (data not shown). Northern blot 
analysis of total RNA isolated from glands of wild-type fe­
males at various stages during pregnancy (P9-18) and at par­
turition (LI) revealed that LAR expression during pregnancy 
is developmentally regulated (Fig. 4). LAR expression is evi­
dent at day 9 of gestation, increases five-fold during mid­
pregnancy and reaches maximum levels at Day 16. Since 
GAPDH expression might vary during pregnancy, as was 
found during lactation (Bahler et ah, 1993), the variations 
in the amount of RNA loaded was also assessed by hybridiz­
ing the blot with a 28S rRNA cDNA probe. The obtained 
LAR expression profile is consistent with a role for LAR 
during mammary gland development at late pregnancy. The 
expression pattern of the LAR-like RPTPases was also in-
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FIG. 4. Regulation of LAR expression during postnatal develop­
m ent of wild-type mammary gland. Total RNA isolated from 
mouse mammary gland at various stages during pregnancy (P) and 
at parturition (L, lactating) was analyzed by Northern blotting. The 
blot was subsequently hybridized with cDNA probes for mouse 
LAR, PTP<5, PTPcr, rat GAPDH, and 28S RNA (28S). The numbers 
indicate the stage of gestation (in days) at which the mammary 
glands were dissected.
log lactation in LARn -y l -r +/”, and LAR"7" females which 
could lactate (Fig. 5B; and data not shown). The 1 urn in a 
were extended and contained secretion. In contrast, less
tional case of a nonlactating LAR female which pups 
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an extended lumen was abrogated in nonlactating mice. 
The development of mammary glands from nonlactating 
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analysis (data not shown). Thus, ductal outgrowth and
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Alveoli in Nonlactating LAR ~ Females
To examine whether the lactational defect found in 
LAR"7” female mice could result from an impaired m am ­
mary gland development, we histologically analyzed m am ­
mary glands from virgin, late pregnant, postpartum, lactat ­
ing, and involuting female mice. We termed LAR*7' 
"nonlactating" if they consistently showed for two or three 
successive
after birth. LAR“7" females which were indistinguishable
2 mice regarding the percentage of surviving 
pups per litter were considered as "lactating” LAR“7“ mice. 
We observed no significant difference in the number of 
ducts per unit volume of fat pad in glands of virgin 
LAR+7+, LAR+/~, and lactating LAR"7”' females (data not
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shown). Extensive alveolar development was observed cltir 200 fi,m,
FIG. 5. Histological an? 
nonlactating LAR'7” (A) and LAR+/~ (B), The former Litters of the 
LAR'“7" female died within the first 3 days after birth, but th is  time 
the litter was nursed very poorly and the last pups died a t Day 7. 
For the ~ 5 0 % of females that show the nonlactating phenotype, 
this was the only exception for which we could monitor a lacta­
tional state. The fat pad of the LAR“7"“ mice is not completely filled 
and the alveoli are overall smaller than those in hernizygous and 
wild-type mice (not shown). The epithelial cells in the  LAR“7“ mice 
do not. have a secretory appearance as witnessed by their cuboidal 
appearance and flattened apical side (arrow in A). In contrast, milk 
is visible in the hernizygous mice, both as proteinacious luminal 
content and as Intracellular secretory products (arrow in B). Bar,
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FIG. 6. Aberrant development; at late pregnancy resulting in impaired functional differentiation at parturition in LAR 1 m am m ary  
glands. Haernatoxy 1 in eosi.n staining of mam mary glands at late pregnancy (Day 18.5; A and B) and at parturition (C and D) from a wild-
type female (A and C) and a nonlactating LAR“ female (B and D), Only minor differences in lumen size and alveoli cluster formation 
can be observed at late pregnancy, Tissues from wild-type mice contain more intraluminal secretion (arrow in A). In contrast, secretion 
appears more intracellular in nonlactating LAR“7” glands as indicated by the high content of Lipid droplets in epithelial cells (arrow in B).
C i
:v a is c»; î in gial nds from nonlactating LAR 1 females at parturition. The num ber and size of
alveoli are reduced. Furthermore, signs of local interstitial fibrosis (arrow in D) and congestion of secretion are visible. Barr 30 /¿m.
The formation of thebranching is not overtly impaired, 
lobuloalveolar structures was examined in more detail by 
histological analysis using haematoxylin-eosin (Figs. 6A 
and 6B) or oil-red 0  staining (data not shown) of mammary
r-\ r*
However, clear
glands at late pregnancy. Only minor differences in 
size and alveoli cluster formation were 
wild-type and nonlactating LAR 7 
differences in the morphology of secretory epithelial cells 
and luminal contents were evident. While intraluminal se­
cretions were visible in glands from wild-type mice
6A)t the LAR”7” epithelial cells contained 
vesicles and lipid droplets 
(Fig. 6B).
At parturition, enlarged alveoli with extended lumina
g an secretion
were clearly visible in wild-type glands (Fig, 6C). In contrast,
and size of alveoli in nonlacta ting LAR~/~' were
S6~
cretion could be observed (Fig, 6D). Whole m ount analysis 
of mammary glands isolated from nonlactating LAR~/_" 
mothers at parturition showed an advanced state of involu­
tion (Figs. 7C-F). Although there is unavoidable variation 
1 n t hi e m oi n e n t: o f t. i s s u e c o 11 e c ti o n , t  h e i nv o I u t  i o n s t a te i s
type mice 2 days after removal of their pups (Fig. 7A) and 
in some cases already resembles complete involution as ob­
served for wild-type mice at 2 weeks following weaning of 
the pups which had been nursed for 
T o te s't w h e t h ti r a I i ere d e x p res s 1 o n o f rn i I k p r o t e i n genes
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could explain the failure of nonlactating L A R "7" females to 
switch to the lactational state, R N A  was isolated and 
probed for W D N M 1 , W A P , /?-casein, and a-lactalbumin 
transcript levels by Northern blot analysis. No  differences 
were apparent between nonlactating L A R "7- and wild-type 
mice (data not shown). Also, immmunohistochemical 
staining for W A P  expression did not point to altered milk 
protein synthesis (data not shown). Moreover, the protein 
and triglycerides content of the few microliters that inci­
dentally could be obtained from nonlactating mice is com­
parable to that of wild-type and lactating L A R “7“ mice (data 
not shown).
Pups did recognize, attach, and bite the nipple of their 
mothers, but in about half of the L A R '7- females alveolar 
development which is characteristic for late pregnancy was 
not attained and milk secretion was not initiated. Moreover, 
the transition to involution and apoptosis of alveolar epithe­
lium occured more readily in these mice, even before milk 
secretion started. These findings suggest an impaired devel­
opment of mammary alveoli in L A R -/" females at late preg­
nancy: the failure of the alveoli to acquire secretory activity 
is paralleled by a rapid involution at parturition.
D I S C U S S I O N
To address the biological role of LA R  PTPase activity in 
growth and development we generated mice lacking expres­
sion of the LA R  PTPase cytoplasmic region. The L A R "7" 
mice are viable, grow, and behave normally. Furthermore, 
histological analysis of a wide variety of tissues at different 
ages did not reveal structural abnormalities, consistent with 
a previous report on the generation of LAR-deficient mice 
using a gene trap-based method capturing the N-terminal 
signal sequence and generating a /?-galactosidase fusion pro­
tein (Skarnes e t  ah, 1995). However, our current detailed 
analysis reveals that L A R  has a function during mammary 
gland differentiation. W e observed an increased neonatal 
mortality for pups from L A R -7- mothers, independent of 
the litter size and the geno type of the male or the offspring. 
The pups suckled the nipples of their mother, but failed to 
ingest milk, became dehydrated and died. Swapping experi­
ments demonstrated that the increased neonatal death was 
due to a lactational defect of the L A R "7" mothers rather 
than to an abnormal behavior of neonatal pups. Due to ge­
netic background heterogeneity this phenotype displayed a 
5 0 %  penetrance in the F2 hybrid 129X C57BL/6 mice that 
were used in this study, which might explain why it was 
not detected by Skarnes e t  a l  (1995). Interestingly, also in 
D rosophila  the inactivation of CAM-like RPTPases resulted 
in phenotypes with a limited penetrance (Desai e t a l ,  1996; 
Krueger e t a l ,  1996). To map potential modifier loci, it will 
be necessary to cross the LA R  allele into different genetic 
backgrounds. Regarding ductal outgrowth and branching in 
wild-type mammary glands, we did not observe significant 
background differences between mouse strain 129, C57BL/ 
6, the F2 hybrid 129X C57B1/6, and F4 mice on C57BL/6
background, although the ductal system at the virgin state 
in 129 mice is less developed.
Development of the mammary gland progresses gradually 
during puberty and pregnancy and acquires full function 
during lactation (for review see Daniel and Silberstein, 
1987). In several natural mouse mutants, as well as 
transgenic and knock-out mice this process is affected (Cal­
lahan etal, 1996; Jhappan e t a l . , 1992, 1993; Kordon e t a l ., 
1995; Li e t a l ,  1994, 1996a,b; Robinson e t a l ,  1996; Sicinski 
e t  ah, 1995). For example, in transgenic mice expressing 
TG F a  under the control of the mouse W A P  gene promoter 
mammary development and differentiation proceeds during 
pregnancy, but the secretory cells do not establish and/or 
maintain a functional state characterized by milk secretion 
(Robinson et  a l ,  1996; Sandgren et a l ,  1995). A  similar 
phenotype was observed in mice which contain a nonfunc­
tional mCSFl (Pollard and Hennighausen, 1994) or inhibin 
/?B gene (Vassalli et a l ,  1994). The high amounts of intracel­
lular fat droplets at late pregnancy is also seen in “milchlos” 
transgenic mice (Robinson et  a l ,  1995). In nonlactating 
L A R "7" mice a normal epithelial cell proliferation up to late 
pregnancy is observed, but histological sections of glands 
at late pregnancy showed a more intracellular storage of 
secretion products in comparison with the intraluminal se­
cretion in wild-type glands. At parturition, mammary 
glands showed a regression of alveolar structures as is seen 
normally at a progressed stage of involution following wean­
ing of the pups. Taken together, these observations suggest 
that LAR  function is evoked relatively late in mammary 
gland development and that most likely the L A R "/_ pheno­
type is a combination of a loss of alveolar cells around partu­
rition and the inability of the remaining alveoli to undergo 
secretory differentiation.
Complex molecular interactions are involved in the regu­
lation of lactation (Rillema, 1994). The initiation of lacta­
tion following parturition involves many endocrine 
changes, of which the reduced influence of sex steroid hor­
mones appears to be the most important (for review see 
Daniel and Silberstein, 1987; Rillema, 1994). Hormonal in­
fluences at the level of some milk protein gene promoters 
are mediated by the mammary gland-specific transcription 
factor MGF/Stat5 (Wakao e t  a l ,  1994). Regulation of milk 
protein expression via regulation of StatS activity also re­
quires the basement membrane (Sympson e t a l ,  1994; Tal- 
houk et  a l ,  1992), which provides signals via interaction 
with epithelial cells through cell surface receptors (Streuli 
e t  a l ,  1995). Mice lacking Stat5a show reduced mammary 
lobuloalveolar outgrowth and fail to lactate due to an im­
paired terminal differentiation (Liu e t a l , 1997). The pheno­
type becomes apparent during midpregnancy and is re­
flected by a marked reduction in W A P  transcript levels. 
LA R  deficient mice show signs of abnormal mammary 
gland development at a later stage, shortly before parturi­
tion, and no reduction in W A P  levels could be observed. It 
remains to be investigated whether or not LAR  and STAT5a  
signalling pathways are intertwined at some stage of m am ­
mary gland development.
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LAR is expressed in brain and therefore could perhaps 
piay a role in the regulation of the appropriate hormone 
balance needed for proper mammary gland development and 
function. However, at the moment it is not known if LAR 
is specifically localized to regions in the brain that are in­
volved in the hormonal regulation of lactation and further 
studies will be required to address this issue. LAR is pre­
dominantly expressed in epithelial cells and localized at 
regions of association of these cells and the basement mem­
brane (Streuli etal, 1992). Consistent with this is the recent 
finding of colocalization of LAR and its interacting protein 
LIP.l at focal adhesions and its proposed role in disassembly 
of focal adhesions (Serra-Pagfes et ah, 1995). In view of the 
developmental regulation of LAR expression in the mam­
mary gland during pregnancy and the phenotypic conse­
quences of the ablation of LAR PTPase activity, these data 
point to an important role for LAR in cell-matrix interac­
tions that are crucial for mammary gland development and 
function.
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